CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

If you are severely congested, here's one move to clear a stuffy nose. It works so well, you'll want to bookmark this video.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

As a young child, I was often laid up by hay fever, as well as by allergies to things like dog hair and house dust mites.

Saline nasal drops also help flush out mucous and inflammatory mediators, which can improve cold symptoms and give the immune ...